Amgen Inc. (AMGN) Stock Quote

Detailed Quote for Amgen Inc. (AMGN)

close 52 Week Information

52 Week High

February 2, 2012

Close: 70.00

52 Week Low

August 11, 2011

Close: 47.6607

Today

Last Price
66.93

Change $
0.09

Change %
0.13%

Tick

Bid
66.92

Bid Size
300

Ask
66.94

Ask Size
1,000

Open
66.90

High
67.10

Low
66.80

Prev Close
66.84

Last Trade
10:55

Volume
1.42 m

52 Wk Hi
70.00

52 Wk Low
47.6607

Market Cap
58.67 b

Ex-Div Date
2/13/12

Div Rate
1.44

Yield
2.1544

Shares
876,544,275

EPS (TTM)
4.04

PE Ratio
16.50

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Amgen Inc. (AMGN)

Sector News | Topic News

News for AMGN

Wed, Feb 08, 2012

8:00 AM

Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting - PR Newswire

Thu, Feb 02, 2012

8:00 AM

Equity Research on Amgen Inc. and Biogen Idec Inc. - Biotech Industry Growing - Marketwire

Thu, Jan 26, 2012

4:01 PM

Amgen's Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33 - PR Newswire

9:36 AM

Amgen to Acquire Micromet - PR Newswire

8:00 AM

Amgen to Acquire Micromet - PR Newswire

Tue, Jan 24, 2012

4:05 PM

Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results - PR Newswire

Tue, Jan 10, 2012

9:00 AM

Dako and Amgen to Collaborate in Development of a Companion Diagnostic for an Amgen Investigational Cancer Therapy - Marketwire

Mon, Jan 09, 2012

5:15 AM

SEP and SSE Join Forces to Establish New £95 Million Green Energy Fund - PR Newswire

Thu, Jan 05, 2012

3:30 AM

SEP Raises £200 Million for New Growth Equity and Venture Fund - PR Newswire

Wed, Jan 04, 2012

4:09 PM

Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference - PR Newswire

Thu, Dec 29, 2011

5:32 PM

FDA to Review Potential New Use of XGEVA® (Denosumab) at Oncologic Drugs Advisory Committee Meeting - PR Newswire

Mon, Dec 19, 2011

4:05 PM

Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars - PR Newswire

4:00 PM

Amgen and Watson Announce Collaboration to Develop and Commercialize Oncology Biosimilars - PR Newswire

Thu, Dec 15, 2011

4:36 PM

Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012 - PR Newswire

4:01 PM

Amgen Announces 2012 First Quarter Dividend - PR Newswire

Wed, Dec 14, 2011

9:28 AM

Amgen Announces Final Results of Its Tender Offer - PR Newswire

Tue, Dec 13, 2011

4:11 PM

Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim) - PR Newswire

Fri, Dec 09, 2011

4:31 PM

Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference - PR Newswire

Thu, Dec 08, 2011

8:00 AM

Amgen Announces Preliminary Results of Its Tender Offer - PR Newswire

Wed, Dec 07, 2011

9:01 AM

A Change in Tides - Featured Research on Regeneron Pharmaceuticals, Inc. and Amgen, Inc. - Marketwire

More News for AMGN >>

Tags for Amgen Inc.

Research stocks or mutual funds related to Amgen Inc. by keywords or tags. Find companies that have a similar focus to AMGN. The keywords below have been associated to AMGN by either user submission or electronic means.

science minerals life science marketing biotechnology company science research papers philanthropy medical expenses philanthropy fundraising pharmaceutical market Commercial Physical And Biological Research (8731) generic pharmaceutical care medical equipment global medical medical journals niche pharmaceutical medical product corporate computer science degree medical product development diabetes patients medical device sales biotechnology market pharmaceutical research and development patient identification patient survey medical label life science manufacturer epoetin pharmaceutical manufacturing company dupont pharmaceuticals care medical supply science medical Biological Products pharma marketing nurse treatment medical surgical pharmaceutical software pharma manufacturing pharma license corporate identity medical librarian pfizer pharmaceutical company patient safety nurse patient care science magazines lupus patients leukemia patients medical marketing pharma consulting r&d manufacturing medical surgical nursing